Skip to main content

Table 2 Adjusted Odds Ratios with 95% Confidence Intervals for missing stage by patient characteristics, England, 2013

From: Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013

 

Cancer patients

 

Colon cancer

Non-small cell lung cancer

Breast cancer

 

Model 1a

Model 2 b

Model 1a

Model 2 b

Model 1 a

Model 2 b

 

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

OR

95% CI

Age at diagnosis

 15–64

1

 

1

 

1

 

1

 

1

 

1

 

 65–74

0.91

(0.80–1.03)

0.78

(0.36–1.71)

0.98

(0.85–1.12)

0.88

(0.48–1.62)

1.13

(0.93–1.36)

1.05

(0.55–2.03)

 75–84

1.13

(1.01–1.28)

1.61

(0.84–3.11)

1.21

(1.05–1.38)

1.10

(0.60–2.01)

1.46

(1.23–1.74)

1.85

(1.06–3.24)

 85+

1.84

(1.63–2.09)

2.80

(1.43–5.49)

2.08

(1.80–2.39)

2.77

(1.48–5.19)

2.15

(1.80–2.56)

3.71

(2.11–6.49)

Sex

 Male

1

 

1

 

1

 

1

     

 Female

1.09

(1.00–1.18)

1.49

(0.97–2.29)

1.05

(0.96–1.15)

1.11

(0.75–1.63)

    

Income deprivation group

 More affluent

1

 

1

 

1

 

1

 

1

 

1

 

 More deprived

0.98

(0.90–1.06)

1.07

(0.70–1.66)

0.91

(0.83–1.00)

1.06

(0.68–1.65)

0.81

(0.72–0.91)

0.92

(0.63–1.35)

Emergency presentation

 No

1

 

1

 

1

 

1

 

1

 

1

 

 Yes

0.93

(0.84–1.02)

1.01

(0.65–1.57)

0.97

(0.89–1.07)

0.50

(0.31–0.78)

1.24

(1.07–1.45)

1.23

(0.71–2.14)

Death within 30 days of diagnosis

 No

1

 

1

 

1

 

1

 

1

 

1

 

 Yes

1.63

(1.44–1.85)

1.26

(0.70–2.27)

2.62

(2.37–2.89)

4.91

(3.14–7.69)

1.87

(1.47–2.38)

2.55

(1.14–5.68)

Surgical procedure

 No

1

 

1

 

1

 

1

 

1

 

1

 

 Yes

0.44

(0.40–0.48)

0.30

(0.19–0.48)

0.68

(0.58–0.79)

0.95

(0.47–1.90)

0.23

(0.20–0.28)

0.31

(0.20–0.49)

Charlson comorbidity index

 0

1

 

1

 

1

 

1

 

1

 

1

 

 1–2

1.16

(1.05–1.28)

1.40

(0.86–2.29)

1.00

(0.91–1.11)

1.07

(0.69–1.67)

1.08

(0.95–1.24)

0.95

(0.61–1.46)

  > =3

1.34

(1.17–1.53)

1.26

(0.65–2.42)

1.17

(1.03–1.32)

1.01

(0.55–1.84)

1.24

(1.05–1.46)

1.72

(0.98–3.03)

  1. OR odds ratio, 95% CI 95% confidence interval
  2. a Model including the whole sample of patients b Model including only patients in the Clinical Commissioning Groups with high stage completeness
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us